You are here

Article info

Article menu
Research letter
The impact of azithromycin therapy on the airway microbiota in asthma

Authors

  1. Correspondence to Dr Kenneth Bruce, King's College London, Molecular Microbiology Research Laboratory, Institute of Pharmaceutical Science, 150 Stamford Street, London SE1 9NH, UK; kenneth.bruce{at}kcl.ac.uk
View Full Text

Citation

Slater M, Rivett DW, Williams L, et al
The impact of azithromycin therapy on the airway microbiota in asthma
Thorax 2014;69:673-674.

Publication history

  • Received September 15, 2013
  • Revised November 5, 2013
  • Accepted November 6, 2013
  • First published November 28, 2013.
Online issue publication 
September 01, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/